Proteomic approaches to identify biomarkers predictive of radiotherapy outcomes

References

• Haimovitz-Friedman A, Kan CC, Ehleiter D et al. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J. Exp. Med. 180(2), 525–535 (1994).
   PubMed Web of Science ®Google Scholar
• Corre I, Niaudet C, Paris F. Plasma membrane signaling induced by ionizing radiation. Mutat. Res. 704(1–3), 61–67 (2010).
   Google Scholar
• Mothersill C, Seymour CB. Radiation-induced bystander effects – implications for cancer. Nat. Rev. Cancer 4(2), 158–164 (2004).
   PubMed Web of Science ®Google Scholar
• Parsons WB Jr, Watkins CH, Pease GL, Childs DS Jr. Changes in sternal marrow following roentgen-ray therapy to the spleen in chronic granulocytic leukemia. Cancer 7(1), 179–189 (1954).
   PubMed Web of Science ®Google Scholar
• Nagasawa H, Little JB. Induction of sister chromatid exchanges by extremely low doses of α-particles. Cancer Res. 52(22), 6394–6396 (1992).
   PubMed Web of Science ®Google Scholar
• Deshpande A, Goodwin EH, Bailey SM, Marrone BL, Lehnert BE. α-particle-induced sister chromatid exchange in normal human lung fibroblasts: evidence for an extranuclear target. Radiat. Res. 145(3), 260–267 (1996).
   PubMed Web of Science ®Google Scholar
• Bentzen SM. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat. Rev. Cancer 6(9), 702–713 (2006).
   PubMed Web of Science ®Google Scholar
• Tucker SL, Thames HD Jr. The effect of patient-to-patient variability on the accuracy of predictive assays of tumor response to radiotherapy: a theoretical evaluation. Int. J. Radiat. Oncol. Biol. Phys. 17(1), 145–157 (1989).
   PubMed Web of Science ®Google Scholar
• Tubiana M. Repopulation in human tumors. A biological background for fractionation in radiotherapy. Acta Oncol. 27(2), 83–88 (1988).
   PubMed Web of Science ®Google Scholar
• Gray LH, Conger AD, Ebert M, Hornsey S, Scott OC. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br. J. Radiol. 26(312), 638–648 (1953).
   PubMed Web of Science ®Google Scholar
• Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br. J. Cancer 9(4), 539–549 (1955).
   PubMed Web of Science ®Google Scholar
• Gerweck LE, Vijayappa S, Kurimasa A, Ogawa K, Chen DJ. Tumor cell radiosensitivity is a major determinant of tumor response to radiation. Cancer Res. 66(17), 8352–8355 (2006).
   PubMed Web of Science ®Google Scholar
• Bourhis J, Dendale R, Hill C et al. Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 Gy in 7 weeks. Int. J. Radiat. Oncol. Biol. Phys. 35(3), 471–476 (1996).
   PubMedGoogle Scholar
• Geara F, Girinski TA, Chavaudra N et al. Estimation of clonogenic cell fraction in primary cultures derived from human squamous cell carcinomas. Int. J. Radiat. Oncol. Biol. Phys. 21(3), 661–665 (1991).
   PubMed Web of Science ®Google Scholar
• Eschwege F, Bourhis J, Girinski T et al. Predictive assays of radiation response in patients with head and neck squamous cell carcinoma: a review of the Institute Gustave Roussy experience. Int. J. Radiat. Oncol. Biol. Phys. 39(4), 849–853 (1997).
   PubMed Web of Science ®Google Scholar
• Höckel M, Vorndran B, Schlenger K, Baussmann E, Knapstein PG. Tumor oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervix. Gynecol. Oncol. 51(2), 141–149 (1993).
   PubMed Web of Science ®Google Scholar
• Lartigau E, Le Ridant AM, Lambin P et al. Oxygenation of head and neck tumors. Cancer 71(7), 2319–2325 (1993).
   PubMed Web of Science ®Google Scholar
• Brahme A. Biologically optimized 3-dimensional in vivo predictive assay-based radiation therapy using positron emission tomography–computerized tomography imaging. Acta Oncol. 42(2), 123–136 (2003).
   PubMed Web of Science ®Google Scholar
• Dancik GM, Ru Y, Owens CR, Theodorescu D. A framework to select clinically relevant cancer cell lines for investigation by establishing their molecular similarity with primary human cancers. Cancer Res. 71(24), 7398–7409 (2011).
   Google Scholar
• Masters JR. Human cancer cell lines: fact and fantasy. Nat. Rev. Mol. Cell Biol. 1(3), 233–236 (2000).
   PubMed Web of Science ®Google Scholar
• Ramsamooj P, Kasid U, Dritschilo A. Differential expression of proteins in radioresistant and radiosensitive human squamous carcinoma cells. J. Natl Cancer Inst. 84(8), 622–628 (1992).
   Google Scholar
• Lin TY, Chang JT, Wang HM et al. Proteomics of the radioresistant phenotype in head-and-neck cancer: Gp96 as a novel prediction marker and sensitizing target for radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 78(1), 246–256 (2010).
   Google Scholar
• Feng XP, Yi H, Li MY et al. Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics. Cancer Res. 70(9), 3450–3462 (2010).
   PubMed Web of Science ®Google Scholar
• Wu P, Zhang H, Qi L et al. Identification of ERp29 as a biomarker for predicting nasopharyngeal carcinoma response to radiotherapy. Oncol. Rep. 27(4), 987–994 (2012).
   PubMed Web of Science ®Google Scholar
• Skvortsova I, Skvortsov S, Stasyk T et al. Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells. Proteomics 8(21), 4521–4533 (2008).
   Google Scholar
• Wang T, Tamae D, LeBon T, Shively JE, Yen Y, Li JJ. The role of peroxiredoxin II in radiation-resistant MCF-7 breast cancer cells. Cancer Res. 65(22), 10338–10346 (2005).
   PubMedGoogle Scholar
• Smith L, Qutob O, Watson MB et al. Proteomic identification of putative biomarkers of radiotherapy resistance: a possible role for the 26S proteasome? Neoplasia 11(11), 1194–1207 (2009).
   PubMed Web of Science ®Google Scholar
• Allal AS, Kähne T, Reverdin AK, Lippert H, Schlegel W, Reymond MA. Radioresistance-related proteins in rectal cancer. Proteomics 4(8), 2261–2269 (2004).
   Google Scholar
• Little JB. Genomic instability and bystander effects: a historical perspective. Oncogene 22(45), 6978–6987 (2003).
   PubMed Web of Science ®Google Scholar
• Dörr W, Hendry JH. Consequential late effects in normal tissues. Radiother. Oncol. 61(3), 223–231 (2001).
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Thames HD, Overgaard M. Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study. Radiother. Oncol. 15(3), 267–274 (1989).
   PubMed Web of Science ®Google Scholar
• Eifel PJ, Donaldson SS, Thomas PR. Response of growing bone to irradiation: a proposed late effects scoring system. Int. J. Radiat. Oncol. Biol. Phys. 31(5), 1301–1307 (1995).
   PubMed Web of Science ®Google Scholar
• Johansson S, Svensson H, Denekamp J. Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients. Int. J. Radiat. Oncol. Biol. Phys. 48(3), 745–750 (2000).
   PubMed Web of Science ®Google Scholar
• Stone HB, Coleman CN, Anscher MS, McBride WH. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol. 4(9), 529–536 (2003).
   PubMed Web of Science ®Google Scholar
• Burnet NG, Nyman J, Turesson I, Wurm R, Yarnold JR, Peacock JH. Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity. Lancet 339(8809), 1570–1571 (1992).
   PubMed Web of Science ®Google Scholar
• Geara FB, Peters LJ, Ang KK, Wike JL, Brock WA. Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients. Int. J. Radiat. Oncol. Biol. Phys. 27(5), 1173–1179 (1993).
   PubMed Web of Science ®Google Scholar
• Johansen J, Bentzen SM, Overgaard J, Overgaard M. Evidence for a positive correlation between in vitro radiosensitivity of normal human skin fibroblasts and the occurrence of subcutaneous fibrosis after radiotherapy. Int. J. Radiat. Biol. 66(4), 407–412 (1994).
   PubMed Web of Science ®Google Scholar
• West CM, Elyan SA, Berry P, Cowan R, Scott D. A comparison of the radiosensitivity of lymphocytes from normal donors, cancer patients, individuals with ataxia-telangiectasia (A-T) and A-T heterozygotes. Int. J. Radiat. Biol. 68(2), 197–203 (1995).
   PubMed Web of Science ®Google Scholar
• Jones LA, Scott D, Cowan R, Roberts SA. Abnormal radiosensitivity of lymphocytes from breast cancer patients with excessive normal tissue damage after radiotherapy: chromosome aberrations after low dose-rate irradiation. Int. J. Radiat. Biol. 67(5), 519–528 (1995).
   PubMed Web of Science ®Google Scholar
• Floyd DN, Cassoni AM. Intrinsic radiosensitivity of adult and cord blood lymphocytes as determined by the micronucleus assay. Eur. J. Cancer 30A(5), 615–620 (1994).
   PubMedGoogle Scholar
• Ozsahin M, Ozsahin H, Shi Y, Larsson B, Würgler FE, Crompton NE. Rapid assay of intrinsic radiosensitivity based on apoptosis in human CD4 and CD8 T-lymphocytes. Int. J. Radiat. Oncol. Biol. Phys. 38(2), 429–440 (1997).
   PubMed Web of Science ®Google Scholar
• Zamai L, Falcieri E, Zauli G, Cataldi A, Vitale M. Optimal detection of apoptosis by flow cytometry depends on cell morphology. Cytometry 14(8), 891–897 (1993).
   PubMedGoogle Scholar
• Ozsahin M, Crompton NE, Gourgou S et al. CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patients. Clin. Cancer Res. 11(20), 7426–7433 (2005).
   PubMed Web of Science ®Google Scholar
• Bordón E, Henríquez Hernández LA, Lara PC et al. Prediction of clinical toxicity in localized cervical carcinoma by radio-induced apoptosis study in peripheral blood lymphocytes (PBLs). Radiat. Oncol. 4, 58 (2009).
   PubMed Web of Science ®Google Scholar
• Schnarr K, Boreham D, Sathya J, Julian J, Dayes IS. Radiation-induced lymphocyte apoptosis to predict radiation therapy late toxicity in prostate cancer patients. Int. J. Radiat. Oncol. Biol. Phys. 74(5), 1424–1430 (2009).
   PubMed Web of Science ®Google Scholar
• Azria D, Belkacemi Y, Romieu G et al. Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a Phase 2 randomised trial. Lancet Oncol. 11(3), 258–265 (2010).
   PubMed Web of Science ®Google Scholar
• Azria D, Ozsahin M, Kramar A et al. Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy. Clin. Cancer Res. 14(19), 6284–6288 (2008).
   PubMed Web of Science ®Google Scholar
• Lü X, de la Peña L, Barker C, Camphausen K, Tofilon PJ. Radiation-induced changes in gene expression involve recruitment of existing messenger RNAs to and away from polysomes. Cancer Res. 66(2), 1052–1061 (2006).
   PubMed Web of Science ®Google Scholar
• Zhao L, Sheldon K, Chen M et al. The predictive role of plasma TGF-β1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer. Lung Cancer 59(2), 232–239 (2008).
   PubMed Web of Science ®Google Scholar
• Zhao L, Wang L, Ji W et al. Elevation of plasma TGF-β1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung cancer: a combined analysis from Beijing and Michigan. Int. J. Radiat. Oncol. Biol. Phys. 74(5), 1385–1390 (2009).
   Google Scholar
• Hartsell WF, Scott CB, Dundas GS et al. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91–03. Am. J. Clin. Oncol. 30(4), 368–376 (2007).
   PubMed Web of Science ®Google Scholar
• Marchetti F, Coleman MA, Jones IM, Wyrobek AJ. Candidate protein biodosimeters of human exposure to ionizing radiation. Int. J. Radiat. Biol. 82(9), 605–639 (2006).
   PubMed Web of Science ®Google Scholar
• Ménard C, Johann D, Lowenthal M et al. Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis. Cancer Res. 66(3), 1844–1850 (2006).
   PubMed Web of Science ®Google Scholar
• Guipaud O, Holler V, Buard V et al. Time-course analysis of mouse serum proteome changes following exposure of the skin to ionizing radiation. Proteomics 7(21), 3992–4002 (2007).
   Google Scholar
• Ao X, Lubman DM, Davis MA et al. Comparative proteomic analysis of radiation-induced changes in mouse lung: fibrosis-sensitive and -resistant strains. Radiat. Res. 169(4), 417–425 (2008).
   Google Scholar
• Cai XW, Shedden K, Ao X et al. Plasma proteomic analysis may identify new markers for radiation-induced lung toxicity in patients with non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 77(3), 867–876 (2010).
   PubMed Web of Science ®Google Scholar
• Cai XW, Shedden KA, Yuan SH et al. Baseline plasma proteomic analysis to identify biomarkers that predict radiation-induced lung toxicity in patients receiving radiation for non-small cell lung cancer. J. Thorac. Oncol. 6(6), 1073–1078 (2011).
   PubMed Web of Science ®Google Scholar
• Oh JH, Craft JM, Townsend R, Deasy JO, Bradley JD, El Naqa I. A bioinformatics approach for biomarker identification in radiation-induced lung inflammation from limited proteomics data. J. Proteome Res. 10(3), 1406–1415 (2011).
   PubMed Web of Science ®Google Scholar
• Andreassen CN, Alsner J. Genetic variants and normal tissue toxicity after radiotherapy: a systematic review. Radiother. Oncol. 92(3), 299–309 (2009).
   PubMed Web of Science ®Google Scholar